Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|January 1, 1989
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposideM Gore, R Powles, A Lakhani, et al.
Bone Marrow Transplantation|July 1, 1997
Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignanciesJ Mehta, S Kelsey, P Chu, et al.
Bone Marrow Transplantation|January 1, 1996
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemiaJ Mehta, A Mijović, R Powles, et al.
Bone Marrow Transplantation|October 1, 1996
Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporineJ Mehta, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|November 1, 1993
Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemiaC Tiley, R Powles, J Treleaven, et al.
Leukemia & Lymphoma|August 1, 1997
Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemiaR Saso, A Zomas, M Hamblin, et al.
British Journal of Cancer|July 7, 2000
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinomaR Saso, S Kulkarni, P Mitchell, et al.
British Journal of Haematology|April 1, 1997
Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantationA Atra, B Millar, V Shepherd, et al.
Leukemia & Lymphoma|September 1, 1996
High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary resultsJ Mehta, R Powles, S Singhal, et al.
Bone Marrow Transplantation|December 5, 2006
Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled studyB Sirohi, R Powles, G Morgan, et al.
Pageof 19